dihomoγlinolenic acid

Dihomo-γ-linolenic acid (DGLA) 是一种广泛存在于植物体内的脂肪酸，具有抗肿瘤和抗增殖作用，抑制异种移植肿瘤细胞生长，可用于研究类风湿性关节炎、动脉粥样硬化和特应性皮炎等与炎症相关的疾病。

Ethyl dihomo-γ-linolenic acid ethyl ester (ethyl DGLA), an ω-6 fatty acid intermediate ester form, elevates prostaglandin E1(PGE1) and PGE2 secretion in rabbit renal papilla when administered dietarily at a dosage of 1 g/kg per day for 25 days. Additionally, this dosage of ethyl DGLA increases triglyceride levels and enhances the proportion of 20:3ω6 and 20:4ω6 phospholipids in the renal medulla of rabbits. Ethyl DGLA formulations have been employed in managing eczema and inflammatory disorders.

Dihomo-γ-linolenic acid sodium (DGLA; all-cis-8,11,14-Eicosatrienoic acid) 是一种具有抗炎和抗增殖活性的 20 碳 ω-6 脂肪酸。Dihomo-γ-linolenic acid (sodium) 能减轻载脂蛋白 E 缺陷小鼠模型的动脉粥样硬化。

Dihomo-γ-Linolenic acid methyl ester 是 Dihomo-γ-Linolenic acid 的甲酯形式，Dihomo-γ-Linolenic acid 具有抗炎和抗增殖作用。